Xtx Topco LTD Dexcom Inc Transaction History

Xtx Topco LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $508,621 - $623,865	4,453 New	4,453 $617,000
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $160,415 - $257,101	1,864 Added 40.67%	6,447 $601,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $173,653 - $202,233	-1,544 Reduced 25.2%	4,583 $588,000
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $289,952 - $342,700	-2,788 Reduced 31.27%	6,127 $711,000
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $288,677 - $416,709	-3,397 Reduced 27.59%	8,915 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $377,779 - $466,002	4,948 Added 67.19%	12,312 $992,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $354,295 - $692,489	5,211 Added 242.03%	7,364 $549,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $162,193 - $224,464	1,724 Added 401.86%	2,153 $1.1 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $55,714 - $69,849	429 New	429 $230,000
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $161,170 - $214,780	-1,990 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $168,732 - $208,432	1,990 New	1,990 $715,000

1,112

365M

4.1M

3.65M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.